Pfizer Investigational Site — New Brunswick, New Jersey

Pfizer Investigational Site is a clinical research site located in New Brunswick, New Jersey, United States 08903.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Pfizer Investigational Site has participated in 34 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension, Pulmonary Hypertension, Hot Flashes.

Sponsors: Pfizer, Wyeth is now a wholly owned subsidiary of Pfizer, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pfizer Investigational Site?

Pfizer Investigational Site has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pfizer Investigational Site conducted?

Pfizer Investigational Site has 34 clinical trials on record. Their work covers Pulmonary Arterial Hypertension, Pulmonary Hypertension, Hot Flashes.

Is Pfizer Investigational Site accredited by Crixeo Health?

Yes — Pfizer Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Pfizer Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.